Delivery Order SPE2DB22D3102-SPE2DB25FL2EM
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of RotaTeq vaccine (2mL formulation) valued at $10,655.80. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award of the pharmaceutical product. The order is scheduled for ultimate completion on August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $4,150.39 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a $5,327.90 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2mL) on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside contract employs firm fixed-price terms and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,183.46 to AmerisourceBergen Drug Corp for RotaTeq vaccine (2mL) on July 25, 2025, with completion targeted for July 28, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate operations. This delivery order represents a single transaction...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) with a ceiling value of $2,741.22. This firm fixed-price delivery order, issued on August 14, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The contract is set for completion by August 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,327.90 for RotaTeq Vaccine 2ML on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at the company's corporate office location in Conshohocken, PA. The award is funded by the Medical Supply Chain within the Defense logistics structure, supporting federal medical procurement needs. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,111.83 by the Defense Logistics Agency (DLA) on July 23, 2025, with an ultimate completion date of July 24, 2025. The delivery order covers RotaTeq vaccine in 2 mL quantities and is structured as a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is located in...
- The U.S. Defense Logistics Agency (DLA) awarded a $38,380.44 firm fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of RotaTeq vaccine (2 mL). This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the RotaTeq vaccine in 2 milliliter doses. The $1,992.88 firm-fixed-price contract has an ultimate completion date of April 26, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The order is for the RotaTeq vaccine, a 2-milliliter rotavirus vaccine, with a firm fixed price of $2,524.05 and a completion date of August 9, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2EMDelivery Order
The Defense Logistics Agency (DLA) awarded a $1,076.56 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2mL) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract utilized no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued against AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 pharmaceutical prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products, vaccines, and medical supplies to support military healthcare worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for Defense Health Agency and military healthcare systems. The company's portfolio encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific vaccine delivery order reflects the company's ongoing role in fulfilling federal pharmaceutical supply requirements through open competition, demonstrating its capability to support military medical logistics on both routine and specialized procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/22/25 |